Navigation Links
Endovascular Forum and GEST Set Out on a Shared Venture to Bring the Highest Level of Embolization-based Scientific and Technical Education, Results, and Relevance for Patient Care
Date:11/11/2009

BOSTON, Nov. 11 /PRNewswire/ -- The Endovascular Forum (EVF), an IC Sciences company, announces today a new partnership with the Global Embolization Symposium and Technologies (GEST), and the launch of a dynamic online case-based interactive forum.

This endeavor is in line with the GEST mission and aim of bringing practitioners the highest level of scientific and technical education about the use of new materials and devices, their results, relevance for patient care, imaging, and to fine tune existing skills and expertise in these areas in the most innovative and dynamic method possible.

"This partnership between GEST, the world's leader in innovative and comprehensive forum for embolization science and education, and the Endovascular Forum, the premier innovative online community for endovascular physicians, is a beautiful match," said Dr. Ziv Haskal, one of the three co-founders of GEST. "We are very excited about linking our community with the far reach and vision of the EVF."

Embolization is one of the few areas in endovascular therapy that draws together all practitioners, regardless of their individual subspecialty practices. Obviously, for the interventional oncologist, embolization is the sine qua non. However, embolization spans peripheral vascular disease, trauma, visceral artery and venous interventions, pediatric and neurointerventional therapies, women's health, aortic disease, vascular malformations, gastrointestinal bleeding, liver disease, non-vascular procedures, cell-based therapies, etc.

In turn embolotherapy has become a central part of daily Interventional Radiology work. Embolization indications have substantially increased over the last decade and continue to do so. Fibroid embolization, trauma, and GI-hemorrhage are only a few areas manifesting this fast increase. Additionally, treatment of vascular malformations is fully dependent on embolization techniques. Oncology treatment with drug-eluting and target-specific beads is another fast-growing field of embolization indication.

"We are excited to count GEST as our most recent partner in the further development of the Endovascular Forum's clinical exchange platform," said Rony Sellam, Chief Strategy and Business Development Officer for IC Sciences. "The course directors' bold vision for applied learning and international diversity of perspectives is squarely aligned with the Forum's strengths and aspirations as we become the online destination of choice for cardiovascular and endovascular specialists worldwide."

The EVF and GEST collaboration will further continue to advance embolization knowledge and practice. This is a shared venture where an educational meeting and web-based forum combine to ensure that no part of this ever growing and developing discipline is left untouched.

About the Endovascular Forum. Founded in 1996, the Endovascular Forum is the world's longest standing medical forum dedicated to endovascular specialists. The EVF is an international case study and discussion forum developed and hosted by IC Sciences Corporation (www.ICSciences.com). The EVF members come together to share clinical observations, findings, and cases that all serve to accelerate the awareness and adoption of the most innovative and sometimes controversial procedures among physicians in the minimally invasive medical community. To learn more about the Endovascular Forum, visit www.Endovascular.org or call 866-804-6296.

About GEST

The GEST Meeting is the original and largest embolization meeting and the only one to focus upon a truly global and unique educational experience. It delivers the 'total' educational and professional know-how, by merging signature live demonstrations, master classes, hands-on attendee events, in-depth technical sessions, evidence-based review, research presentations, and case-based teaching. After three successful meetings in Europe, drawing thousands of total attendees from over 70 different countries, the meeting is coming to San Francisco from May 6 - 9, 2010. For more information about GEST, visit www.gestweb.org.

About IC Sciences Corporation. IC Sciences Corporation is a closely held, private organization pioneering in the medical information sciences and informed clinical technology markets. The company's core business involves designing, developing, delivering, and advancing a series of informatics instrument classes, including care delivery, cognitive profiling, collective intelligence, therapeutic support, and performance evaluation. For more information, please visit: www.ICSciences.com.

    Contact:
    IC Sciences Corporation
    Public Relations
    (http://www.icsciences.com/contactus.cfm)
    One Joy Street
    Boston, MA 02108
    1-866-804-6296

SOURCE IC Sciences Corporation


'/>"/>
SOURCE IC Sciences Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. CardioVascularCS.Org, a division of EndoVascular Forum, Inc., Partners with Complex Interventional Cardiovascular Therapy (CICT) to Extend Electronic Medical Care Advancement
2. Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series
3. Abaxis, Inc. to Present at the Sidoti & Company Second Annual New York Institutional Investor Forum
4. Cantel Medical Corp. to Present at the Sidoti Emerging Growth Research Institutional Investor Forum
5. Palatin Technologies to Present at 8th Annual BIO Investor Forum
6. Trubion Announces Upcoming Presentation at 8th Annual BIO Investor Forum
7. Cell Therapeutics, Inc. (CTI) to Present at 8th Annual BIO Investor Forum
8. Novavax to Present at 8th Annual BIO Investor Forum 2009
9. Micromet to Present at The 8th Annual BIO Investor Forum Conference on October 29, 2009
10. VirtualScopics to Present at the 8th Annual Bio Investor Forum
11. Marc J. Fagel of the U.S. Securities and Exchange Commission to Discuss SEC Enforcement at CBIs Biotech/Pharma Finance and Accounting Forum in San Francisco
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 23, 2016  MedSource announced today that it ... software solution of choice.  This latest decision demonstrates ... to their clients by offering a state-of-the-art electronic ... establishes nowEDC as the EDC platform of choice ... clients.  "nowEDC has long been a preferred EDC ...
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... Research and Markets has announced the ... 2016 - Forecast to 2022" report to their offering. ... up to date financial data derived from varied research sources ... with potential impact on the market during the next five ... comprises of sub markets, regional and country level analysis. The ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health and ... their exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards took ... the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to receive ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle ... chronic pain and the benefits of holistic treatments, Serenity Recovery Center of ... Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, ... treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including robotic ... osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It ...
(Date:6/24/2016)... ... 24, 2016 , ... EB Medicine presented its first-ever “Issue ... conference in Ponte Vedra Beach, FL. The awards honor the outstanding work of ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the placement of ... President of North American Capital Sales at HTG Molecular . , ... the commercialization of the HTG EdgeSeq system and associated reagents in North America. , ...
Breaking Medicine News(10 mins):